Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

16
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

19
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

23
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
23
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

26
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
26
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

834
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
834

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial.

The New England journal of medicine·2026
Same author

A Cost Analysis of Intravascular Ultrasound during Lower Extremity Deep Venous Interventions among Medicare Beneficiaries.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Team-based approach to deep venous disease: A multidisciplinary approach to the multifaceted problem of thrombotic lower extremity venous disease.

Seminars in vascular surgery·2025
Same author

Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases.

Journal of vascular and interventional radiology : JVIR·2024
Same author

Venous Interventions: Controversies in the Management of Acute Deep Venous Thrombosis and the Role of the Interventional Radiologist.

Radiologic clinics of North America·2024
Same author

Transvenous Tissue Sampling in the Diagnosis of Intravascular Neoplasm.

Radiology. Imaging cancer·2024

Related Experiment Video

Updated: Aug 20, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.8K

Antithrombotic Therapy after Deep Venous Intervention.

Nicholas Xiao1, Matthew Genet1, Minhaj Khaja2

  • 1Division of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.

Seminars in Interventional Radiology
|November 21, 2022
PubMed
Summary
This summary is machine-generated.

Managing anticoagulation after deep venous stent placement for chronic venous disease (CVD) remains unclear. This review summarizes current literature and proposes an approach to antithrombotic therapy for improved patient outcomes in venous stent management.

Keywords:
anticoagulationdeep venous thrombosisinterventional radiologypostthrombotic syndromevenous

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.4K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

710

Related Experiment Videos

Last Updated: Aug 20, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.8K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.4K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

710

Area of Science:

  • Vascular Medicine
  • Interventional Cardiology
  • Venous Thromboembolism

Background:

  • Chronic deep venous disease (CVD) significantly impacts quality of life, causing symptoms like edema and ulcers.
  • CVD can stem from thrombotic events (e.g., deep vein thrombosis) or non-thrombotic causes (e.g., iliac vein compression).
  • Endovascular therapy, including venous stent placement, is a primary treatment for CVD.

Purpose of the Study:

  • To address the lack of established guidelines for anticoagulation post-venous stent placement.
  • To summarize existing literature on antithrombotic management following deep venous interventions.
  • To propose a practical approach to anticoagulation and antiplatelet therapy for CVD patients.

Main Methods:

  • Comprehensive review of current literature on anticoagulation and antiplatelet therapy after venous stent placement.
  • Analysis of existing datasets, acknowledging limitations due to outdated information and practice heterogeneity.
  • Synthesis of findings to develop a proposed management strategy.

Main Results:

  • The optimal antithrombotic regimen following venous stent placement for CVD is not well-defined by large trials or consensus.
  • Significant heterogeneity exists in current practice patterns and data collection for antithrombotic management.
  • Existing studies are often limited by outdated techniques and technologies in deep venous intervention.

Conclusions:

  • There is a critical need for standardized antithrombotic protocols after deep venous interventions for CVD.
  • Evidence-based guidelines are required to optimize anticoagulation and antiplatelet strategies.
  • Further research is essential to establish best practices in managing patients with venous stents for CVD.